Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NURO 0.821 +0.041 (5.26%)
price chart
NeuroMetrix, Inc. Announces Date for 2015 Second Quarter Financial Results ...
WALTHAM, Mass., Jul 15, 2015 (BUSINESS WIRE) -- NeuroMetrix, Inc. NURO, +1.11% announced today that it plans to issue its 2015 second quarter financial results before the opening of the market on July 22, 2015.
NeuroMetrix, Inc. (NASDAQ:NURO) Short Interest Update
NeuroMetrix, Inc. (NASDAQ:NURO) has witnessed a drop of 14.4% or 45,835 shares in its short figure. The short interest diminution took it from 317,445 on June 30,2015 to 271,610 on July 15,2015.
NeuroMetrix Inc.
NeuroMetrix is a publicly traded (NASDAQ:NURO) innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
Company Shares of NeuroMetrix, Inc. Drops by -18.68%
NeuroMetrix, Inc. (NASDAQ:NURO) has lost 18.68% during the past week and dropped 18.33% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 16.84%.
NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 ...
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
Related articles »  
Neurometrix Inc (NURO): Is NeuroMetrix A Good Buy?
NeuroMetrix (NASDAQ:NURO) is a medical device company that develops and markets devices for the treatment and management of the neurological complications of diabetes.
NeuroMetrix Inc.: NeuroMetrix Reports Q2 2015 Financial Results and Highlights
NeuroMetrix management will host a conference call today, July 22, 2015 at 8:00 a.m., Eastern Time. To access the call in the United States, dial 877-703-6102 and use the confirmation code 94747742.
Neurometrix (NURO) Issues Earnings Results  Dakota Financial News
NeuroMetrix Showcases Quell™ Wearable Pain Relief Technology at the ...  Business Wire (press release)
NeuroMetrix, Inc. Short Interest Update
NeuroMetrix, Inc. (NASDAQ:NURO), A drop of 241,269 shares or 44.6% was seen in the short interest of NeuroMetrix, Inc.. Even as the interest dropped from 540,684 shares on May 29,2015 to 299,415 shares on June 15,2015, the days to cover came in at 1.
This Week's Morning Info: NeuroMetrix Inc. (NURO), Citizens Financial Group ...
NeuroMetrix Inc. (NURO) finished down on Fri with a 7 day performance of -18.68% finishing the day at $0.74, a loss of -3.88%.
NeuroMetrix Skyrockets On FDA Approval For Its Wearable Device
NeuroMetrix Inc. (NURO) soared over 30% after the Food and Drug Administration (FDA) approved the company's pain relieving wearable device for over-the-counter sale in the US.
NeuroMetrix gets clearance to market an over-the-counter pain management device  Boston Globe
With consumer product, NeuroMetrix CEO says he'll need to open a new ...  Boston Business Journal (blog)
Related articles »